InvestorsHub Logo
Followers 5
Posts 776
Boards Moderated 0
Alias Born 04/13/2012

Re: None

Tuesday, 12/04/2012 2:40:33 PM

Tuesday, December 04, 2012 2:40:33 PM

Post# of 80490
from time to time, i have heard that we are at the current price per share because of the high marks ponatnib has received. and that the price reflects a pre-determined approval from the fda. If thats the case, does anyone think that the price should go higher upon an actual approval, as i think it should? Or at this point, does a separate catalyst need to take place, in order to breath in a new life of highs, from its current price?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.